WallStSmart

CRA International Inc (CRAI)vsEquifax Inc (EFX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Equifax Inc generates 700% more annual revenue ($6.59B vs $823.67M). EFX leads profitability with a 11.3% profit margin vs 6.3%. CRAI appears more attractively valued with a PEG of 1.29. EFX earns a higher WallStSmart Score of 68/100 (B-).

CRAI

Buy

64

out of 100

Grade: C+

Growth: 7.3Profit: 6.5Value: 4.7Quality: 5.0
Piotroski: 3/9Altman Z: 2.37

EFX

Strong Buy

68

out of 100

Grade: B-

Growth: 7.3Profit: 7.0Value: 3.3Quality: 5.5
Piotroski: 6/9Altman Z: 1.90
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRAISignificantly Overvalued (-79.3%)

Margin of Safety

-79.3%

Fair Value

$91.52

Current Price

$210.94

$119.42 premium

UndervaluedFair: $91.52Overvalued
EFXSignificantly Overvalued (-15.3%)

Margin of Safety

-15.3%

Fair Value

$171.36

Current Price

$189.50

$18.14 premium

UndervaluedFair: $171.36Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRAI3 strengths · Avg: 8.3/10
Return on EquityProfitability
24.1%9/10

Every $100 of equity generates 24 in profit

Revenue GrowthGrowth
15.6%8/10

15.6% revenue growth

EPS GrowthGrowth
26.9%8/10

Earnings expanding 26.9% YoY

EFX2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.0%8/10

Strong operational efficiency at 21.0%

EPS GrowthGrowth
38.8%8/10

Earnings expanding 38.8% YoY

Areas to Watch

CRAI4 concerns · Avg: 3.0/10
Market CapQuality
$1.24B3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.3%3/10

6.3% margin — thin

Debt/EquityHealth
1.193/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EFX4 concerns · Avg: 3.8/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

P/E RatioValuation
30.5x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.904/10

Grey zone — moderate risk

Debt/EquityHealth
1.163/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CRAI

The strongest argument for CRAI centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 15.6% demonstrates continued momentum. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bull Case : EFX

The strongest argument for EFX centers on Operating Margin, EPS Growth.

Bear Case : CRAI

The primary concerns for CRAI are Market Cap, Profit Margin, Debt/Equity.

Bear Case : EFX

The primary concerns for EFX are PEG Ratio, P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

CRAI profiles as a growth stock while EFX is a value play — different risk/reward profiles.

EFX carries more volatility with a beta of 1.27 — expect wider price swings.

CRAI is growing revenue faster at 15.6% — sustainability is the question.

EFX generates stronger free cash flow (437M), providing more financial flexibility.

Bottom Line

EFX scores higher overall (68/100 vs 64/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CRA International Inc

INDUSTRIALS · CONSULTING SERVICES · USA

CRA International, Inc., a consulting firm, provides economic, financial and management consulting services in the United States, the United Kingdom, and internationally. The company is headquartered in Boston, Massachusetts.

Equifax Inc

INDUSTRIALS · CONSULTING SERVICES · USA

Equifax Inc. is an American multinational consumer credit reporting agency and is one of the three largest consumer credit reporting agencies, along with Experian and TransUnion. In addition to credit and demographic data and services to business, Equifax sells credit monitoring and fraud prevention services directly to consumers.

Want to dig deeper into these stocks?